In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
UK-based drugmaker GlaxoSmithKline has announced that its chief financial officer Simon Dingemans is to retire. 10 May 2018
Biotechnology
Horizon Discovery’s announcement on the identity of its new chief executive on Monday has been followed on Tuesday by a major drop in the share price of the gene editing company. 9 May 2018
Pharmaceutical
French independent pharma company Pierre Fabre has named Eric Ducournau as its new chief executive, taking over from Bertrand Parmentier who has announced his retirement. 7 May 2018
Pharmaceutical
US pharma major Eli Lilly today announced that Leena Gandhi, a prestigious thoracic oncologist with a focus on immunotherapy and early drug development, will join Lilly Oncology on June 25, 2018 to lead immuno-oncology medical development. 2 May 2018
Pharmaceutical
Grünenthal has announced that Philip Just Larsen is to join the company chief scientific officer (CSO) and member of the corporate executive board. 30 April 2018
Pharmaceutical
The British and Irish arm of Japanese pharma titan Takeda has announced the promotion of Jon Neal to the role of managing director. 27 April 2018
Biotechnology
Omeicos Opthalmics, a subsidiary of German biotech Omeicos Therapeutics, has named Alexander Gebauer as its first chief executive. 27 April 2018
Biotechnology
UK biotech firm Redx Pharma today announced the appointment of Lisa Anson as chief executive and to its board of directors 24 April 2018
Pharmaceutical
Danish specialty pharma company Xellia Pharmaceuticals has named the leader of its oncoming assault on the US market. 23 April 2018
Generics
German drugmaker Stada Arzneimittel has snapped up senior executives from Sandoz, Biogen and Pfizer to be part of its management team. 20 April 2018
Pharmaceutical
A month after US healthcare giant Johnson & Johnson announced that its chief financial officer (CFO) Dominic Caruso was to retire after 12 years in the role and Takeda's finance boss left his job with the Japanese firm, France’s biggest pharma company has said that it is losing its long-standing CFO. 19 April 2018
Pharmaceutical
Novartis’ Vas Narasimhan, who became chief executive of the company on February 1, has now found a replacement for his previous post as head of global drug development (GDD) and chief medical officer, naming John Tsai to the position. 19 April 2018
Pharmaceutical
GlaxoSmithKline today revealed is has appointed Kevin Sin as senior vice president and head of worldwide business development for pharmaceuticals research and development. 18 April 2018
Biotechnology
Nordic Nanovector saw its share plunge 9.66% to 4.21 euros as markets opened this mornings, after the Norway-based biotech firm revealed that its chief executive, Luigi Costa, will step down from the post by mutual agreement with the board of directors. 5 April 2018
Biotechnology
US gene therapy developer Abeona Therapeutics has lured one of the most experienced names in rare diseases to become its new chief executive. 3 April 2018
Pharmaceutical
Dermavant has expanded not just its pipeline, but also its executive team, the dermatology specialist announced on Monday. 3 April 2018
Biotechnology
Celgene Corp on Monday announced that Scott Smith, president and chief operating officer (COO), is leaving the company effective immediately. 3 April 2018
Pharmaceutical
Menarini, one of Italy’s largest pharma companies and still headed by the founding Aleotti family, has decided to entrust the chairmanship of the company to an external manager coming from a large multinational, Dr Eric Cornut. 29 March 2018
Pharmaceutical
After 19 years with the US healthcare giant Johnson & Johnson (NYSE: JNJ), Dominic Caruso, executive vice president, chief financial officer, has elected to retire in September 2018. 22 March 2018
Pharmaceutical
Christine Roy-Duval has left her role as international clinical investigation director at French pharma major Sanofi’s diabetes unit to join metabolic diseases specialist Valbiotis. 21 March 2018
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze